Company Long-Term Loans and Borrowings: Lipocine Corp (LPCN)

Public company logo of Lipocine Corp (LPCN)

Lipocine Inc. (LPCN) specializes in developing innovative drug delivery systems to combat metabolic disorders. This price chart reflects the performance of the company, which carries a debt of 0.00. The business targets men's health clinics by offering an oral alternative to testosterone injections. High academic standing and the trust endocrinologists place in the brand's scientific foundation ensure steady loyalty from pragmatic investors.

LPCN Lipocine Inc. Company Long-Term Debts (07/04/2022 - 10/30/2026)

Summary analytical data breakdowns for Lipocine Corp (LPCN)

- market price and analyst price targets:
Stock Price lipocine.com|LPCN - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Lipocine|LPCN - Total Company Value
- book capitalization information:
Accounting Value per Share Lipocine|LPCN - Book Capitalization|Market Capitalization to Book Value Ratio lipocine.com|LPCN - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Lipocine Inc.|LPCN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Lipocine Corporation|LPCN - Company Aggregate Debts|Debts to Book Value Lipocine|LPCN - Company Long-Term Liabilities|Amount of Current Liabilities Lipocine|Quick Ratio lipocine.com
- earnings and multiples data:
LPCN - Net Profit
Summary company analytics:Lipocine Inc.
Brand item of Lipocine Inc.

This metric aggregates total liabilities with a maturity of more than one year, allowing for an assessment of the capital structure's stability and default risk relative to US industry benchmarks. Given the development of metabolic drugs within the protected legal environment of the US, the history of long-term loans and borrowings of Lipocine Inc. (LPCN) reflects the actual cost of financing innovation, excluding geopolitical sanction risks.

Competitor analysis for Lipocine Inc.

Company Long-Term Debts ascendispharma.com ASND|MDGL - Company Long-Term Debt|Company Long-Term Loans and Borrowings CORT (Corcept Therapeutics Inc.)|Rhythm Pharmaceuticals Inc (RYTM) - Company Long-Term Debt|Company Long-Term Liabilities Akero Corp|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com|Company Long-Term Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Soleno SLNO|FOLD - Company Long-Term Liabilities|89bio, Inc. - Company Long-Term Debts|Long-Term Debt agios.com|GPCR (Structure Therapeutics Inc.) - Company Long-Term Liabilities|MDXG: Amount of Long-Term Liabilities|RZLT (Rezolute Corp) - Company Long-Term Debts|Company Long-Term Debts Lexicon Corp|Company Long-Term Debts MBX|Company Long-Term Debt ALT (altimmune.com)|Company Long-Term Debt Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. (SGMT) - Long-Term Debt|BIOA - Company Long-Term Debt|BMEA: Company Long-Term Debt|QNCX: Company Long-Term Debts|GUTS - Long-Term Debt Volume|Company Long-Term Debt vTv Therapeutics, Inc.|Agape ATP Corp. (ATPC) - Long-Term Debt Volume|Company Long-Term Debt Pluri Inc. (PLUR)|Company Long-Term Liabilities synlogictx.com SYBX|Company Long-Term Debt Matinas BioPharma Holdings MTNB|Spruce Biosciences Inc. - Company Long-Term Debt|Galecto - Company Long-Term Debts|Long-Term Debt Volume Carmell Corp. CTCX|Lumos Pharma Corp (LUMO) - Company Long-Term Debt|Long-Term Liabilities ONVO (Organovo Corp)|Company Long-Term Debt Radius Recycling, Inc.